Awareness of Iron Status Evaluation in UGIB

Awareness of the Need for the Evaluation of Iron Status Among Hospitalized Patients With Acute Upper Gastrointestinal Bleeding.

NCT06299007•Hat Yai Medical Education Center

View on ClinicalTrials.gov

Summary

BACKGROUND: Data on the awareness of the need to evaluate iron status and IDA prevalence in acute UGIB are limited. OBJECTIVES: This study aimed to investigate the rate of evaluation of iron status and prevalence of iron deficiency anemia (IDA) and the associated factors in patients with anemia hospitalized for acute upper gastrointestinal bleeding (UGIB).

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•patients \> 18 years of age who were admitted because of acute UGIB and were diagnosed with anemia from UGIB during hospitalization.

Exclusion Criteria

•patients who had previously undergone endoscopy at another institution before admission
•patients who had a definite cause of UGIB that was inconclusive
•incomplete data for analysis.

Locations (1)

Hatyai Hospital

Hat Yai, Changwat Songkhla, Thailand

Key Dates

Start Date

August 1, 2023

Primary Completion Date

December 31, 2023

Completion Date

December 31, 2023

Last Updated

March 7, 2024

Enrollment

867

ACTUAL participants

Conditions

Upper Gastrointestinal Bleeding

The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper GI Bleeding

NCT07261228

Carbon Footprint in Upper GI EndoscopyDyspepsia+1 more

View study

COMPLETEDPHASE3

Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding

NCT06297954

Upper Gastrointestinal Bleeding

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 7, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Awareness of Iron Status Evaluation in UGIB

Inclusion Criteria

Exclusion Criteria

The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper GI Bleeding

Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding

Single-use Versus Reusable Gastroscopes in Patients With Upper Gastrointestinal Bleeding.

PillSense System for Detecting UGI Bleed

Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study

Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease